Frequencies for first 10,000 rows of indi_pt variable in indi2006q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 3 0.03 0.03 ABDOMINAL PAIN | 21 0.21 0.24 ABDOMINAL PAIN LOWER | 2 0.02 0.26 ABDOMINAL PAIN UPPER | 2 0.02 0.28 ABNORMAL BEHAVIOUR | 4 0.04 0.32 ABSCESS | 7 0.07 0.39 ABSCESS DRAINAGE | 1 0.01 0.40 ACCIDENTAL EXPOSURE | 1 0.01 0.41 ACID FAST BACILLI INFECTION | 1 0.01 0.42 ACNE | 39 0.39 0.81 ACNE CONGLOBATA | 3 0.03 0.84 ACNE CYSTIC | 1 0.01 0.85 ACQUIRED IMMUNODEFICIENCY SYNDROME | 22 0.22 1.07 ACROMEGALY | 1 0.01 1.08 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 1 0.01 1.09 ACUTE CORONARY SYNDROME | 4 0.04 1.13 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 1.14 ACUTE LYMPHOCYTIC LEUKAEMIA | 23 0.23 1.37 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 4 0.04 1.41 ACUTE MYELOID LEUKAEMIA | 21 0.21 1.62 ACUTE MYELOID LEUKAEMIA RECURRENT | 3 0.03 1.65 ACUTE MYOCARDIAL INFARCTION | 39 0.39 2.04 ACUTE PROMYELOCYTIC LEUKAEMIA | 13 0.13 2.17 ADDISON'S DISEASE | 2 0.02 2.19 ADENOCARCINOMA | 3 0.03 2.22 ADENOCARCINOMA PANCREAS | 3 0.03 2.25 ADENOSQUAMOUS CELL LUNG CANCER | 4 0.04 2.29 ADRENAL CORTICAL INSUFFICIENCY | 1 0.01 2.30 ADRENAL INSUFFICIENCY | 3 0.03 2.33 ADRENOGENITAL SYNDROME | 2 0.02 2.35 AFFECT LABILITY | 2 0.02 2.37 AFFECTIVE DISORDER | 8 0.08 2.45 AGGRESSION | 2 0.02 2.47 AGITATION | 8 0.08 2.55 AGRANULOCYTOSIS | 1 0.01 2.56 ALANINE AMINOTRANSFERASE INCREASED | 1 0.01 2.57 ALCOHOL USE | 1 0.01 2.58 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 2.59 ALCOHOLISM | 2 0.02 2.61 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 5 0.05 2.66 ALOPECIA | 4 0.04 2.70 AMNESIA | 4 0.04 2.74 AMOEBIASIS | 1 0.01 2.75 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.76 ANAEMIA | 21 0.21 2.97 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 2.98 ANAEMIA OF CHRONIC DISEASE | 1 0.01 2.99 ANAEMIA OF MALIGNANT DISEASE | 6 0.06 3.05 ANAEMIA PROPHYLAXIS | 2 0.02 3.07 ANAEMIA VITAMIN B12 DEFICIENCY | 1 0.01 3.08 ANAESTHESIA | 5 0.05 3.13 ANAL FISTULA | 1 0.01 3.14 ANALGESIC EFFECT | 15 0.15 3.29 ANALGESIC THERAPY | 1 0.01 3.30 ANAPLASTIC LARGE CELL LYMPHOMA T- AND.. | 3 0.03 3.33 ANGER | 3 0.03 3.36 ANGINA PECTORIS | 21 0.21 3.57 ANGIOPATHY | 1 0.01 3.58 ANKYLOSING SPONDYLITIS | 20 0.20 3.78 ANOGENITAL WARTS | 1 0.01 3.79 ANOREXIA | 2 0.02 3.81 ANTI-INFECTIVE THERAPY | 2 0.02 3.83 ANTIBIOTIC PROPHYLAXIS | 21 0.21 4.04 ANTICOAGULANT THERAPY | 9 0.09 4.13 ANTIDEPRESSANT THERAPY | 3 0.03 4.16 ANTIEMETIC SUPPORTIVE CARE | 7 0.07 4.23 ANTIFUNGAL PROPHYLAXIS | 4 0.04 4.27 ANTIINFLAMMATORY THERAPY | 2 0.02 4.29 ANTIPHOSPHOLIPID SYNDROME | 3 0.03 4.32 ANTIPLATELET THERAPY | 2 0.02 4.34 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 1 0.01 4.35 ANTIPYRESIS | 1 0.01 4.36 ANTISOCIAL BEHAVIOUR | 1 0.01 4.37 ANTIVIRAL PROPHYLAXIS | 31 0.31 4.68 ANXIETY | 72 0.72 5.40 ANXIETY DISORDER | 9 0.09 5.49 AORTIC DISSECTION | 2 0.02 5.51 AORTIC VALVE DISEASE | 1 0.01 5.52 AORTIC VALVE REPLACEMENT | 2 0.02 5.54 APLASIA | 9 0.09 5.63 APLASTIC ANAEMIA | 1 0.01 5.64 ARRHYTHMIA | 11 0.11 5.75 ARTERIAL BYPASS OPERATION | 1 0.01 5.76 ARTERIAL DISORDER | 1 0.01 5.77 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.78 ARTERIOGRAM CORONARY | 1 0.01 5.79 ARTERIOSCLEROSIS CORONARY ARTERY | 4 0.04 5.83 ARTERIOSCLEROSIS OBLITERANS | 3 0.03 5.86 ARTERIOVENOUS MALFORMATION | 1 0.01 5.87 ARTHRALGIA | 14 0.14 6.01 ARTHRITIS | 33 0.33 6.34 ARTHRITIS BACTERIAL | 2 0.02 6.36 ARTHROPOD BITE | 2 0.02 6.38 ASCITES | 4 0.04 6.42 ASPERGILLOSIS | 2 0.02 6.44 ASTHENIA | 1 0.01 6.45 ASTHMA | 133 1.33 7.78 ASTHMATIC CRISIS | 1 0.01 7.79 ATRIAL FIBRILLATION | 50 0.50 8.29 ATRIAL FLUTTER | 4 0.04 8.33 ATRIAL TACHYCARDIA | 2 0.02 8.35 ATRIOVENTRICULAR BLOCK | 1 0.01 8.36 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 27 0.27 8.63 AUTISM | 4 0.04 8.67 AUTISM SPECTRUM DISORDER | 1 0.01 8.68 AUTOIMMUNE DISORDER | 1 0.01 8.69 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 8.70 B-CELL LYMPHOMA | 5 0.05 8.75 BACK INJURY | 1 0.01 8.76 BACK PAIN | 54 0.54 9.30 BACTERIAL INFECTION | 6 0.06 9.36 BARRETT'S OESOPHAGUS | 1 0.01 9.37 BASEDOW'S DISEASE | 1 0.01 9.38 BEHCET'S SYNDROME | 5 0.05 9.43 BENIGN PROSTATIC HYPERPLASIA | 29 0.29 9.72 BILIARY CANCER METASTATIC | 2 0.02 9.74 BILIARY NEOPLASM | 6 0.06 9.80 BIPOLAR DISORDER | 55 0.55 10.35 BIPOLAR I DISORDER | 12 0.12 10.47 BLADDER CANCER | 15 0.15 10.62 BLADDER CANCER RECURRENT | 1 0.01 10.63 BLADDER NEOPLASM | 1 0.01 10.64 BLEPHAROSPASM | 2 0.02 10.66 BLOOD BICARBONATE DECREASED | 1 0.01 10.67 BLOOD CHOLESTEROL | 11 0.11 10.78 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 10.80 BLOOD CHOLESTEROL INCREASED | 49 0.49 11.29 BLOOD DISORDER | 1 0.01 11.30 BLOOD GLUCOSE INCREASED | 3 0.03 11.33 BLOOD IRON INCREASED | 7 0.07 11.40 BLOOD MAGNESIUM DECREASED | 1 0.01 11.41 BLOOD POTASSIUM | 1 0.01 11.42 BLOOD PRESSURE | 17 0.17 11.59 BLOOD PRESSURE ABNORMAL | 1 0.01 11.60 BLOOD PRESSURE DIASTOLIC INCREASED | 1 0.01 11.61 BLOOD PRESSURE INCREASED | 9 0.09 11.70 BLOOD PRODUCT TRANSFUSION DEPENDENT | 1 0.01 11.71 BLOOD PROLACTIN INCREASED | 1 0.01 11.72 BLOOD TESTOSTERONE DECREASED | 1 0.01 11.73 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 11.75 BLOOD URINE PRESENT | 1 0.01 11.76 BONE CANCER METASTATIC | 2 0.02 11.78 BONE DENSITY DECREASED | 3 0.03 11.81 BONE MARROW TRANSPLANT | 9 0.09 11.90 BONE NEOPLASM | 3 0.03 11.93 BONE NEOPLASM MALIGNANT | 1 0.01 11.94 BONE PAIN | 6 0.06 12.00 BONE SCAN | 1 0.01 12.01 BORDERLINE PERSONALITY DISORDER | 3 0.03 12.04 BRADYCARDIA | 1 0.01 12.05 BRAIN ABSCESS | 4 0.04 12.09 BRAIN NEOPLASM | 3 0.03 12.12 BRAIN OEDEMA | 5 0.05 12.17 BREAKTHROUGH PAIN | 4 0.04 12.21 BREAST CANCER | 95 0.95 13.16 BREAST CANCER FEMALE | 6 0.06 13.22 BREAST CANCER METASTATIC | 26 0.26 13.48 BREAST CANCER RECURRENT | 3 0.03 13.51 BREAST NEOPLASM | 1 0.01 13.52 BRONCHIAL DISORDER | 3 0.03 13.55 BRONCHIAL OBSTRUCTION | 1 0.01 13.56 BRONCHIECTASIS | 1 0.01 13.57 BRONCHITIS | 11 0.11 13.68 BRONCHITIS ACUTE | 17 0.17 13.85 BRONCHITIS CHRONIC | 1 0.01 13.86 BRONCHOPNEUMONIA | 2 0.02 13.88 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 13.89 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC | 2 0.02 13.91 BRONCHOSPASM | 3 0.03 13.94 CAESAREAN SECTION | 1 0.01 13.95 CALCIPHYLAXIS | 1 0.01 13.96 CALCIUM DEFICIENCY | 1 0.01 13.97 CANCER PAIN | 25 0.25 14.22 CANDIDA PNEUMONIA | 1 0.01 14.23 CANDIDIASIS | 7 0.07 14.30 CARCINOID SYNDROME | 3 0.03 14.33 CARCINOMA IN SITU OF BLADDER | 5 0.05 14.38 CARDIAC ANEURYSM | 1 0.01 14.39 CARDIAC ASSISTANCE DEVICE USER | 1 0.01 14.40 CARDIAC DISORDER | 10 0.10 14.50 CARDIAC FAILURE | 32 0.32 14.82 CARDIAC FAILURE CHRONIC | 3 0.03 14.85 CARDIAC FAILURE CONGESTIVE | 11 0.11 14.96 CARDIAC VALVE DISEASE | 1 0.01 14.97 CARDIOMYOPATHY | 2 0.02 14.99 CARDIOMYOPATHY NEONATAL | 2 0.02 15.01 CARDIOVASCULAR DISORDER | 10 0.10 15.11 CARDIOVASCULAR EVENT PROPHYLAXIS | 4 0.04 15.15 CARDIOVERSION | 1 0.01 15.16 CARPAL TUNNEL SYNDROME | 1 0.01 15.17 CATAPLEXY | 1 0.01 15.18 CATARACT | 2 0.02 15.20 CATHETER SITE HAEMORRHAGE | 1 0.01 15.21 CATHETERISATION CARDIAC | 2 0.02 15.23 CELLULITIS | 7 0.07 15.30 CENTRAL NERVOUS SYSTEM LYMPHOMA | 39 0.39 15.69 CEREBRAL ARTERY EMBOLISM | 2 0.02 15.71 CEREBRAL DISORDER | 1 0.01 15.72 CEREBRAL HAEMORRHAGE | 5 0.05 15.77 CEREBRAL INFARCTION | 16 0.16 15.93 CEREBROVASCULAR ACCIDENT | 12 0.12 16.05 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 7 0.07 16.12 CEREBROVASCULAR DISORDER | 6 0.06 16.18 CERUMEN REMOVAL | 1 0.01 16.19 CERVICITIS | 1 0.01 16.20 CERVICOBRACHIAL SYNDROME | 1 0.01 16.21 CERVIX CARCINOMA | 2 0.02 16.23 CHEMICAL POISONING | 1 0.01 16.24 CHEMOTHERAPY | 20 0.20 16.44 CHEST PAIN | 10 0.10 16.54 CHEST WALL MASS | 2 0.02 16.56 CHILLS | 1 0.01 16.57 CHOLECYSTITIS | 3 0.03 16.60 CHOLELITHIASIS | 1 0.01 16.61 CHONDROPATHY | 2 0.02 16.63 CHOROIDAL NEOVASCULARISATION | 4 0.04 16.67 CHRONIC HEPATITIS | 1 0.01 16.68 CHRONIC LYMPHOCYTIC LEUKAEMIA | 7 0.07 16.75 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFO.. | 4 0.04 16.79 CHRONIC MYELOID LEUKAEMIA | 39 0.39 17.18 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 50 0.50 17.68 CHRONIC RESPIRATORY FAILURE | 1 0.01 17.69 CHRONIC SINUSITIS | 7 0.07 17.76 COAGULOPATHY | 4 0.04 17.80 COGNITIVE DISORDER | 2 0.02 17.82 COLECTOMY | 2 0.02 17.84 COLITIS | 13 0.13 17.97 COLITIS ULCERATIVE | 20 0.20 18.17 COLON CANCER | 29 0.29 18.46 COLON CANCER METASTATIC | 1 0.01 18.47 COLON CANCER STAGE III | 1 0.01 18.48 COLON CANCER STAGE IV | 2 0.02 18.50 COLORECTAL CANCER | 30 0.30 18.80 COLORECTAL CANCER METASTATIC | 26 0.26 19.06 COLORECTAL CANCER STAGE IV | 6 0.06 19.12 COMPLETED SUICIDE | 2 0.02 19.14 COMPLEX PARTIAL SEIZURES | 2 0.02 19.16 COMPLEX REGIONAL PAIN SYNDROME | 3 0.03 19.19 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 19.20 COMPRESSION FRACTURE | 2 0.02 19.22 COMPUTERISED TOMOGRAM | 4 0.04 19.26 COMPUTERISED TOMOGRAM ABDOMEN | 5 0.05 19.31 CONSTIPATION | 67 0.67 19.98 CONSTIPATION PROPHYLAXIS | 1 0.01 19.99 CONTRACEPTION | 58 0.58 20.57 CONVULSION | 27 0.27 20.84 CONVULSION PROPHYLAXIS | 2 0.02 20.86 CORD BLOOD TRANSPLANT THERAPY | 10 0.10 20.96 CORONARY ANGIOPLASTY | 4 0.04 21.00 CORONARY ARTERY BYPASS | 10 0.10 21.10 CORONARY ARTERY DISEASE | 27 0.27 21.37 CORONARY ARTERY STENOSIS | 1 0.01 21.38 COUGH | 8 0.08 21.46 CROHN'S DISEASE | 87 0.87 22.33 CYSTITIS | 6 0.06 22.39 CYTOMEGALOVIRUS CHORIORETINITIS | 3 0.03 22.42 CYTOMEGALOVIRUS INFECTION | 2 0.02 22.44 DECREASED APPETITE | 2 0.02 22.46 DECUBITUS ULCER | 1 0.01 22.47 DEEP VEIN THROMBOSIS | 15 0.15 22.62 DELIRIUM | 2 0.02 22.64 DELUSION | 5 0.05 22.69 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 22.70 DEMENTIA | 5 0.05 22.75 DEMENTIA ALZHEIMER'S TYPE | 15 0.15 22.90 DENTAL CARE | 2 0.02 22.92 DENTAL DISORDER PROPHYLAXIS | 2 0.02 22.94 DENTAL TREATMENT | 1 0.01 22.95 DEPRESSION | 239 2.39 25.34 DEPRESSIVE SYMPTOM | 1 0.01 25.35 DERMATITIS | 6 0.06 25.41 DERMATITIS ALLERGIC | 1 0.01 25.42 DERMATITIS ATOPIC | 2 0.02 25.44 DERMATITIS CONTACT | 1 0.01 25.45 DEVICE RELATED INFECTION | 3 0.03 25.48 DIABETES INSIPIDUS | 4 0.04 25.52 DIABETES MELLITUS | 225 2.25 27.77 DIABETES MELLITUS INSULIN-DEPENDENT | 38 0.38 28.15 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 73 0.73 28.88 DIABETIC NEPHROPATHY | 2 0.02 28.90 DIABETIC NEUROPATHY | 1 0.01 28.91 DIABETIC RETINOPATHY | 1 0.01 28.92 DIAGNOSTIC PROCEDURE | 1 0.01 28.93 DIALYSIS | 7 0.07 29.00 DIARRHOEA | 30 0.30 29.30 DISBACTERIOSIS | 1 0.01 29.31 DISCOMFORT | 1 0.01 29.32 DISSEMINATED INTRAVASCULAR COAGULATION | 8 0.08 29.40 DISTURBANCE IN ATTENTION | 1 0.01 29.41 DIURETIC THERAPY | 9 0.09 29.50 DIVERTICULITIS | 1 0.01 29.51 DIVERTICULUM | 1 0.01 29.52 DIZZINESS | 1 0.01 29.53 DRUG ABUSER | 7 0.07 29.60 DRUG EXPOSURE DURING PREGNANCY | 13 0.13 29.73 DRUG THERAPY | 1 0.01 29.74 DRUG USE FOR UNKNOWN INDICATION | 938 9.38 39.12 DRUG WITHDRAWAL MAINTENANCE THERAPY | 1 0.01 39.13 DRY EYE | 2 0.02 39.15 DRY MOUTH | 2 0.02 39.17 DRY SKIN | 1 0.01 39.18 DUODENAL ULCER | 1 0.01 39.19 DUODENITIS | 1 0.01 39.20 DYSLIPIDAEMIA | 3 0.03 39.23 DYSMENORRHOEA | 3 0.03 39.26 DYSPEPSIA | 14 0.14 39.40 DYSPHAGIA | 3 0.03 39.43 DYSPNOEA | 9 0.09 39.52 DYSTHYMIC DISORDER | 6 0.06 39.58 DYSURIA | 2 0.02 39.60 EAR INFECTION | 5 0.05 39.65 ECHOCARDIOGRAM | 1 0.01 39.66 ECZEMA | 3 0.03 39.69 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 39.70 EMBOLISM | 1 0.01 39.71 EMPHYSEMA | 5 0.05 39.76 ENCEPHALITIS HERPES | 3 0.03 39.79 ENCEPHALITIS VIRAL | 1 0.01 39.80 END STAGE AIDS | 18 0.18 39.98 ENDOMETRIOSIS | 2 0.02 40.00 ENDOSCOPY | 1 0.01 40.01 ENDOSCOPY GASTROINTESTINAL | 2 0.02 40.03 ENTEROCOLITIS | 2 0.02 40.05 ENURESIS | 1 0.01 40.06 EPIDIDYMITIS | 3 0.03 40.09 EPIDURAL ANAESTHESIA | 6 0.06 40.15 EPIDURITIS | 1 0.01 40.16 EPILEPSY | 49 0.49 40.65 EPINEPHRINE INCREASED | 1 0.01 40.66 ERECTILE DYSFUNCTION | 62 0.62 41.28 ERYTHEMA | 1 0.01 41.29 ERYTHRODERMIC PSORIASIS | 2 0.02 41.31 ESSENTIAL HYPERTENSION | 20 0.20 41.51 ESSENTIAL THROMBOCYTHAEMIA | 2 0.02 41.53 EUPHORIC MOOD | 1 0.01 41.54 EWING'S SARCOMA | 2 0.02 41.56 EX-SMOKER | 4 0.04 41.60 EXTRAPYRAMIDAL DISORDER | 3 0.03 41.63 EXTRASYSTOLES | 1 0.01 41.64 EYE IRRIGATION | 3 0.03 41.67 EYE IRRITATION | 1 0.01 41.68 FABRY'S DISEASE | 14 0.14 41.82 FACIAL NEURALGIA | 1 0.01 41.83 FACIAL SPASM | 1 0.01 41.84 FACTOR IX DEFICIENCY | 2 0.02 41.86 FACTOR V LEIDEN MUTATION | 1 0.01 41.87 FACTOR VIII DEFICIENCY | 12 0.12 41.99 FAMILY STRESS | 1 0.01 42.00 FATIGUE | 1 0.01 42.01 FEBRILE NEUTROPENIA | 2 0.02 42.03 FEELING ABNORMAL | 1 0.01 42.04 FEMORAL ARTERY OCCLUSION | 1 0.01 42.05 FIBROMYALGIA | 14 0.14 42.19 FISTULA | 1 0.01 42.20 FLATULENCE | 2 0.02 42.22 FLUID OVERLOAD | 1 0.01 42.23 FLUID REPLACEMENT | 8 0.08 42.31 FLUID RETENTION | 3 0.03 42.34 FOETAL GROWTH RETARDATION | 1 0.01 42.35 FOLLICULITIS | 1 0.01 42.36 FOOD ALLERGY | 1 0.01 42.37 FUNGAL INFECTION | 6 0.06 42.43 GALLBLADDER DISORDER | 1 0.01 42.44 GASTRIC CANCER | 47 0.47 42.91 GASTRIC DISORDER | 7 0.07 42.98 GASTRIC ULCER | 16 0.16 43.14 GASTRIC ULCER HAEMORRHAGE | 5 0.05 43.19 GASTRINOMA | 2 0.02 43.21 GASTRITIS | 32 0.32 43.53 GASTRITIS ATROPHIC | 2 0.02 43.55 GASTROENTERITIS SALMONELLA | 1 0.01 43.56 GASTROINTESTINAL DISORDER | 8 0.08 43.64 GASTROINTESTINAL HAEMORRHAGE | 1 0.01 43.65 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 43.66 GASTROINTESTINAL STROMAL TUMOUR | 11 0.11 43.77 GASTROOESOPHAGEAL CANCER | 4 0.04 43.81 GASTROOESOPHAGEAL REFLUX DISEASE | 36 0.36 44.17 GASTROOESOPHAGEAL REFLUX PROPHYLAXIS | 1 0.01 44.18 GAUCHER'S DISEASE | 7 0.07 44.25 GENERAL ANAESTHESIA | 3 0.03 44.28 GENERALISED ANXIETY DISORDER | 3 0.03 44.31 GENERALISED NON-CONVULSIVE EPILEPSY | 2 0.02 44.33 GENITAL HAEMORRHAGE | 2 0.02 44.35 GLAUCOMA | 24 0.24 44.59 GLIOBLASTOMA | 3 0.03 44.62 GLIOBLASTOMA MULTIFORME | 1 0.01 44.63 GLIOMA | 2 0.02 44.65 GLIOSARCOMA | 1 0.01 44.66 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 44.67 GLOMERULONEPHRITIS PROLIFERATIVE | 3 0.03 44.70 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 44.71 GLYCOGEN STORAGE DISEASE TYPE II | 3 0.03 44.74 GOUT | 15 0.15 44.89 GOUTY ARTHRITIS | 1 0.01 44.90 GRAFT VERSUS HOST DISEASE | 2 0.02 44.92 GROWTH HORMONE DEFICIENCY | 4 0.04 44.96 GROWTH RETARDATION | 1 0.01 44.97 GYNAECOMASTIA | 1 0.01 44.98 HAEMATOPOIETIC STEM CELL MOBILISATION | 1 0.01 44.99 HAEMATOTOXICITY | 1 0.01 45.00 HAEMATURIA | 3 0.03 45.03 HAEMODIALYSIS | 1 0.01 45.04 HAEMOPHILUS INFECTION | 1 0.01 45.05 HAEMORRHAGE | 9 0.09 45.14 HAIR GROWTH ABNORMAL | 1 0.01 45.15 HALLUCINATION | 1 0.01 45.16 HEADACHE | 17 0.17 45.33 HEART RATE DECREASED | 2 0.02 45.35 HEART RATE INCREASED | 1 0.01 45.36 HEART RATE IRREGULAR | 1 0.01 45.37 HEART TRANSPLANT | 15 0.15 45.52 HEART VALVE REPLACEMENT | 2 0.02 45.54 HELICOBACTER GASTRITIS | 2 0.02 45.56 HELICOBACTER INFECTION | 6 0.06 45.62 HELMINTHIC INFECTION | 1 0.01 45.63 HEPARIN NEUTRALISATION THERAPY | 1 0.01 45.64 HEPATIC CIRRHOSIS | 4 0.04 45.68 HEPATIC HAEMORRHAGE | 2 0.02 45.70 HEPATIC NEOPLASM MALIGNANT | 9 0.09 45.79 HEPATITIS | 2 0.02 45.81 HEPATITIS B | 14 0.14 45.95 HEPATITIS C | 74 0.74 46.69 HEPATITIS C VIRUS | 6 0.06 46.75 HEPATITIS CHRONIC ACTIVE | 2 0.02 46.77 HERNIA REPAIR | 1 0.01 46.78 HERPES SIMPLEX | 8 0.08 46.86 HERPES VIRUS INFECTION | 2 0.02 46.88 HERPES ZOSTER | 28 0.28 47.16 HIATUS HERNIA | 3 0.03 47.19 HICCUPS | 2 0.02 47.21 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 47.23 HIP SURGERY | 1 0.01 47.24 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 47.25 HIV INFECTION | 363 3.63 50.88 HIV TEST POSITIVE | 5 0.05 50.93 HODGKIN'S DISEASE | 3 0.03 50.96 HORMONE REPLACEMENT THERAPY | 21 0.21 51.17 HORMONE THERAPY | 4 0.04 51.21 HOT FLUSH | 2 0.02 51.23 HYPERCALCAEMIA | 6 0.06 51.29 HYPERCHLORHYDRIA | 2 0.02 51.31 HYPERCHOLESTEROLAEMIA | 59 0.59 51.90 HYPERCOAGULATION | 1 0.01 51.91 HYPERGLYCAEMIA | 4 0.04 51.95 HYPERKALAEMIA | 2 0.02 51.97 HYPERKINETIC HEART SYNDROME | 1 0.01 51.98 HYPERLIPIDAEMIA | 57 0.57 52.55 HYPERPARATHYROIDISM | 2 0.02 52.57 HYPERPARATHYROIDISM SECONDARY | 20 0.20 52.77 HYPERPHOSPHATAEMIA | 5 0.05 52.82 HYPERPROLACTINAEMIA | 2 0.02 52.84 HYPERSENSITIVITY | 14 0.14 52.98 HYPERTENSION | 470 4.70 57.68 HYPERTHYROIDISM | 2 0.02 57.70 HYPERTONIA | 1 0.01 57.71 HYPERTONIC BLADDER | 6 0.06 57.77 HYPERTRIGLYCERIDAEMIA | 3 0.03 57.80 HYPERURICAEMIA | 10 0.10 57.90 HYPOAESTHESIA | 1 0.01 57.91 HYPOCALCAEMIA | 1 0.01 57.92 HYPOGAMMAGLOBULINAEMIA | 1 0.01 57.93 HYPOKALAEMIA | 3 0.03 57.96 HYPOMAGNESAEMIA | 3 0.03 57.99 HYPOMANIA | 2 0.02 58.01 HYPOPHOSPHATAEMIA | 1 0.01 58.02 HYPOPITUITARISM | 8 0.08 58.10 HYPOTENSION | 4 0.04 58.14 HYPOTHYROIDISM | 39 0.39 58.53 HYSTERECTOMY | 1 0.01 58.54 ICHTHYOSIS | 1 0.01 58.55 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 58.56 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 58.57 ILEUS PARALYTIC | 1 0.01 58.58 ILL-DEFINED DISORDER | 27 0.27 58.85 IMMUNE SYSTEM DISORDER | 2 0.02 58.87 IMMUNODEFICIENCY | 2 0.02 58.89 IMMUNOSUPPRESSANT DRUG THERAPY | 4 0.04 58.93 IMMUNOSUPPRESSION | 1 0.01 58.94 IMPAIRED GASTRIC EMPTYING | 2 0.02 58.96 IN VITRO FERTILISATION | 4 0.04 59.00 INCONTINENCE | 3 0.03 59.03 INCORRECT DOSE ADMINISTERED | 2 0.02 59.05 INCREASED APPETITE | 1 0.01 59.06 INCREASED BRONCHIAL SECRETION | 2 0.02 59.08 INDUCTION OF ANAESTHESIA | 10 0.10 59.18 INFECTED SEBACEOUS CYST | 1 0.01 59.19 INFECTION | 28 0.28 59.47 INFECTION PROPHYLAXIS | 10 0.10 59.57 INFECTION PROTOZOAL | 1 0.01 59.58 INFECTIVE EXACERBATION OF CHRONIC OBS.. | 3 0.03 59.61 INFERIOR VENA CAVAL OCCLUSION | 2 0.02 59.63 INFERTILITY | 3 0.03 59.66 INFLAMMATION | 14 0.14 59.80 INFLAMMATORY BOWEL DISEASE | 1 0.01 59.81 INFLAMMATORY PAIN | 1 0.01 59.82 INFLUENZA | 9 0.09 59.91 INFLUENZA LIKE ILLNESS | 3 0.03 59.94 INITIAL INSOMNIA | 2 0.02 59.96 INJECTION | 1 0.01 59.97 INJURY | 1 0.01 59.98 INSOMNIA | 81 0.81 60.79 INSULIN-REQUIRING TYPE II DIABETES ME.. | 24 0.24 61.03 INTENTIONAL OVERDOSE | 5 0.05 61.08 INTERNATIONAL NORMALISED RATIO | 1 0.01 61.09 INTERNATIONAL NORMALISED RATIO ABNORMAL | 1 0.01 61.10 INTERSTITIAL LUNG DISEASE | 11 0.11 61.21 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 61.22 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 61.24 INTERVERTEBRAL DISC DISORDER | 3 0.03 61.27 INTESTINAL POLYPECTOMY | 4 0.04 61.31 INTRACARDIAC THROMBUS | 1 0.01 61.32 INTRACRANIAL HAEMATOMA | 1 0.01 61.33 INTRAOCULAR PRESSURE INCREASED | 1 0.01 61.34 IRITIS | 1 0.01 61.35 IRON DEFICIENCY | 1 0.01 61.36 IRON DEFICIENCY ANAEMIA | 3 0.03 61.39 IRON METABOLISM DISORDER | 1 0.01 61.40 IRRITABLE BOWEL SYNDROME | 13 0.13 61.53 ISCHAEMIC CARDIOMYOPATHY | 4 0.04 61.57 JOINT INJECTION | 1 0.01 61.58 JUVENILE ARTHRITIS | 8 0.08 61.66 KAPOSI'S SARCOMA | 2 0.02 61.68 KAWASAKI'S DISEASE | 2 0.02 61.70 KIDNEY TRANSPLANT REJECTION | 2 0.02 61.72 KNEE ARTHROPLASTY | 1 0.01 61.73 KYPHOSIS | 1 0.01 61.74 LABOUR INDUCTION | 3 0.03 61.77 LACTATION DISORDER | 1 0.01 61.78 LARGE INTESTINE CARCINOMA | 1 0.01 61.79 LARYNGEAL CANCER | 1 0.01 61.80 LEARNING DISABILITY | 1 0.01 61.81 LETHARGY | 1 0.01 61.82 LEUKAEMIA | 5 0.05 61.87 LEUKAEMIA PLASMACYTIC | 6 0.06 61.93 LIBIDO DECREASED | 1 0.01 61.94 LICE INFESTATION | 1 0.01 61.95 LIP AND/OR ORAL CAVITY CANCER | 1 0.01 61.96 LIP AND/OR ORAL CAVITY CANCER RECURRENT | 1 0.01 61.97 LIPID METABOLISM DISORDER | 3 0.03 62.00 LIPIDS INCREASED | 2 0.02 62.02 LIVER ABSCESS | 1 0.01 62.03 LIVER TRANSPLANT | 12 0.12 62.15 LOBAR PNEUMONIA | 1 0.01 62.16 LOCAL ANAESTHESIA | 9 0.09 62.25 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 62.28 LUNG ADENOCARCINOMA | 6 0.06 62.34 LUNG ADENOCARCINOMA STAGE III | 3 0.03 62.37 LUNG CANCER METASTATIC | 3 0.03 62.40 LUNG DISORDER | 5 0.05 62.45 LUNG INFECTION | 1 0.01 62.46 LUNG INFECTION PSEUDOMONAL | 3 0.03 62.49 LUNG NEOPLASM MALIGNANT | 19 0.19 62.68 LUNG TRANSPLANT | 15 0.15 62.83 LUTEAL PHASE DEFICIENCY | 2 0.02 62.85 LYME DISEASE | 1 0.01 62.86 LYMPHADENECTOMY | 1 0.01 62.87 LYMPHADENITIS BACTERIAL | 1 0.01 62.88 LYMPHANGITIS | 2 0.02 62.90 LYMPHOCYTIC LEUKAEMIA | 7 0.07 62.97 LYMPHOMA | 22 0.22 63.19 LYMPHOPROLIFERATIVE DISORDER | 3 0.03 63.22 MACULAR DEGENERATION | 12 0.12 63.34 MACULAR OEDEMA | 6 0.06 63.40 MAINTENANCE OF ANAESTHESIA | 2 0.02 63.42 MAJOR DEPRESSION | 14 0.14 63.56 MALABSORPTION | 1 0.01 63.57 MALARIA | 1 0.01 63.58 MALARIA PROPHYLAXIS | 4 0.04 63.62 MALE PATTERN BALDNESS | 5 0.05 63.67 MALIGNANT GLIOMA | 1 0.01 63.68 MALIGNANT LYMPHOID NEOPLASM | 1 0.01 63.69 MALIGNANT MELANOMA | 11 0.11 63.80 MALNUTRITION | 1 0.01 63.81 MANIA | 8 0.08 63.89 MANTLE CELL LYMPHOMA | 4 0.04 63.93 MATERNAL CONDITION AFFECTING FOETUS | 1 0.01 63.94 MEDICAL DIET | 14 0.14 64.08 MENINGITIS | 3 0.03 64.11 MENISCUS OPERATION | 1 0.01 64.12 MENOPAUSAL SYMPTOMS | 8 0.08 64.20 MENOPAUSE | 1 0.01 64.21 MENORRHAGIA | 5 0.05 64.26 MENSTRUAL DISORDER | 3 0.03 64.29 MENSTRUATION IRREGULAR | 2 0.02 64.31 MENTAL DISORDER | 1 0.01 64.32 MENTAL IMPAIRMENT | 1 0.01 64.33 METABOLIC ACIDOSIS | 1 0.01 64.34 METABOLIC DISORDER | 1 0.01 64.35 METABOLIC SYNDROME | 1 0.01 64.36 METASTASES TO ADRENALS | 3 0.03 64.39 METASTASES TO BONE | 44 0.44 64.83 METASTASES TO CENTRAL NERVOUS SYSTEM | 2 0.02 64.85 METASTASES TO CHEST WALL | 1 0.01 64.86 METASTASES TO LUNG | 1 0.01 64.87 METASTASIS | 1 0.01 64.88 METASTATIC GASTRIC CANCER | 2 0.02 64.90 METASTATIC MALIGNANT MELANOMA | 13 0.13 65.03 METASTATIC NEOPLASM | 2 0.02 65.05 METASTATIC RENAL CELL CARCINOMA | 36 0.36 65.41 METASTATIC SQUAMOUS CELL CARCINOMA | 1 0.01 65.42 MICTURITION DISORDER | 1 0.01 65.43 MIGRAINE | 18 0.18 65.61 MIGRAINE PROPHYLAXIS | 6 0.06 65.67 MINERAL SUPPLEMENTATION | 6 0.06 65.73 MITRAL VALVE PROLAPSE | 1 0.01 65.74 MITRAL VALVE REPLACEMENT | 2 0.02 65.76 MIXED CONNECTIVE TISSUE DISEASE | 1 0.01 65.77 MOOD ALTERED | 3 0.03 65.80 MOTION SICKNESS | 2 0.02 65.82 MOTOR DYSFUNCTION | 1 0.01 65.83 MUCOSAL INFLAMMATION | 6 0.06 65.89 MULTIPLE ALLERGIES | 3 0.03 65.92 MULTIPLE MYELOMA | 111 1.11 67.03 MULTIPLE SCLEROSIS | 135 1.35 68.38 MUSCLE RELAXANT THERAPY | 3 0.03 68.41 MUSCLE SPASMS | 8 0.08 68.49 MUSCLE SPASTICITY | 4 0.04 68.53 MUSCULAR WEAKNESS | 1 0.01 68.54 MUSCULOSKELETAL CHEST PAIN | 2 0.02 68.56 MUSCULOSKELETAL PAIN | 5 0.05 68.61 MYALGIA | 9 0.09 68.70 MYASTHENIA GRAVIS | 1 0.01 68.71 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 7 0.07 68.78 MYCOSIS FUNGOIDES | 2 0.02 68.80 MYELODYSPLASTIC SYNDROME | 13 0.13 68.93 MYELOID LEUKAEMIA | 2 0.02 68.95 MYELOPROLIFERATIVE DISORDER | 1 0.01 68.96 MYOCARDIAL INFARCTION | 25 0.25 69.21 MYOCARDIAL ISCHAEMIA | 16 0.16 69.37 MYOFASCIAL PAIN SYNDROME | 1 0.01 69.38 NAIL INFECTION | 1 0.01 69.39 NAIL TINEA | 16 0.16 69.55 NARCOLEPSY | 3 0.03 69.58 NASAL CAVITY CANCER | 1 0.01 69.59 NASAL POLYPS | 1 0.01 69.60 NASOPHARYNGEAL CANCER | 1 0.01 69.61 NASOPHARYNGITIS | 9 0.09 69.70 NAUSEA | 44 0.44 70.14 NECK PAIN | 4 0.04 70.18 NEOPLASM | 3 0.03 70.21 NEOPLASM MALIGNANT | 14 0.14 70.35 NEPHRITIC SYNDROME | 2 0.02 70.37 NEPHROGENIC ANAEMIA | 2 0.02 70.39 NEPHROLITHIASIS | 2 0.02 70.41 NEPHROPATHY | 1 0.01 70.42 NEPHROTIC SYNDROME | 7 0.07 70.49 NERVE COMPRESSION | 1 0.01 70.50 NERVOUS SYSTEM DISORDER | 2 0.02 70.52 NERVOUSNESS | 5 0.05 70.57 NEURALGIA | 30 0.30 70.87 NEUROENDOCRINE TUMOUR | 1 0.01 70.88 NEUROMUSCULAR BLOCKADE REVERSAL | 2 0.02 70.90 NEUROPATHY | 5 0.05 70.95 NEUROPATHY PERIPHERAL | 8 0.08 71.03 NEUROSIS | 1 0.01 71.04 NEUTROPENIA | 6 0.06 71.10 NEUTROPENIC SEPSIS | 3 0.03 71.13 NEUTROPHIL COUNT DECREASED | 1 0.01 71.14 NOCTURIA | 1 0.01 71.15 NON-HODGKIN'S LYMPHOMA | 12 0.12 71.27 NON-HODGKIN'S LYMPHOMA STAGE IV | 3 0.03 71.30 NON-SMALL CELL LUNG CANCER | 144 1.44 72.74 NON-SMALL CELL LUNG CANCER METASTATIC | 3 0.03 72.77 NON-SMALL CELL LUNG CANCER STAGE IIIB | 6 0.06 72.83 NON-SMALL CELL LUNG CANCER STAGE IV | 3 0.03 72.86 NORMAL DELIVERY | 1 0.01 72.87 OBESITY | 3 0.03 72.90 OBSESSIVE-COMPULSIVE DISORDER | 9 0.09 72.99 OCULAR HYPERAEMIA | 1 0.01 73.00 OEDEMA | 11 0.11 73.11 OEDEMA PERIPHERAL | 3 0.03 73.14 OESOPHAGEAL CANDIDIASIS | 2 0.02 73.16 OESOPHAGEAL CARCINOMA | 4 0.04 73.20 OESOPHAGEAL DISORDER | 1 0.01 73.21 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 3 0.03 73.24 OESOPHAGITIS | 2 0.02 73.26 OESOPHAGOGASTRODUODENOSCOPY | 1 0.01 73.27 OESTROGEN REPLACEMENT THERAPY | 3 0.03 73.30 OFF LABEL USE | 1 0.01 73.31 OILY SKIN | 1 0.01 73.32 OLIGOMENORRHOEA | 1 0.01 73.33 ONYCHOMYCOSIS | 1 0.01 73.34 OPHTHALMOLOGICAL EXAMINATION | 2 0.02 73.36 ORAL CANDIDIASIS | 9 0.09 73.45 ORAL CONTRACEPTION | 6 0.06 73.51 ORAL FUNGAL INFECTION | 3 0.03 73.54 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 1 0.01 73.55 ORTHOSTATIC HYPOTENSION | 1 0.01 73.56 OSTEITIS | 4 0.04 73.60 OSTEITIS DEFORMANS | 1 0.01 73.61 OSTEOARTHRITIS | 19 0.19 73.80 OSTEOLYSIS | 1 0.01 73.81 OSTEOMYELITIS | 2 0.02 73.83 OSTEOPENIA | 10 0.10 73.93 OSTEOPOROSIS | 121 1.21 75.14 OSTEOPOROSIS POSTMENOPAUSAL | 7 0.07 75.21 OSTEOPOROSIS PROPHYLAXIS | 7 0.07 75.28 OSTEOSARCOMA LOCALISED | 1 0.01 75.29 OTITIS MEDIA | 1 0.01 75.30 OTITIS MEDIA ACUTE | 2 0.02 75.32 OVARIAN CANCER | 29 0.29 75.61 OVARIAN EPITHELIAL CANCER | 1 0.01 75.62 OVARIAN FAILURE | 1 0.01 75.63 OVERWEIGHT | 1 0.01 75.64 PAIN | 222 2.22 77.86 PAIN IN EXTREMITY | 10 0.10 77.96 PAIN IN JAW | 1 0.01 77.97 PAIN MANAGEMENT | 4 0.04 78.01 PAIN PROPHYLAXIS | 5 0.05 78.06 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 78.07 PALPITATIONS | 1 0.01 78.08 PANCREATIC CARCINOMA | 5 0.05 78.13 PANCREATIC CARCINOMA METASTATIC | 5 0.05 78.18 PANCREATIC INSUFFICIENCY | 2 0.02 78.20 PANCREATITIS | 1 0.01 78.21 PANCREATITIS ACUTE | 1 0.01 78.22 PANCYTOPENIA | 1 0.01 78.23 PANIC ATTACK | 7 0.07 78.30 PANIC DISORDER | 6 0.06 78.36 PARAESTHESIA | 4 0.04 78.40 PARANOIA | 2 0.02 78.42 PARKINSON'S DISEASE | 64 0.64 79.06 PARKINSONISM | 3 0.03 79.09 PARTIAL SEIZURES | 5 0.05 79.14 PARTIAL SEIZURES WITH SECONDARY GENER.. | 1 0.01 79.15 PATENT DUCTUS ARTERIOSUS | 1 0.01 79.16 PELVIC ABSCESS | 1 0.01 79.17 PEMPHIGOID | 2 0.02 79.19 PEPTIC ULCER | 5 0.05 79.24 PERCUTANEOUS CORONARY INTERVENTION | 5 0.05 79.29 PERIARTHRITIS | 1 0.01 79.30 PERICARDITIS | 1 0.01 79.31 PERIPHERAL BLOOD STEM CELL APHERESIS | 1 0.01 79.32 PERIPHERAL VASCULAR DISORDER | 1 0.01 79.33 PERITONEAL DIALYSIS | 5 0.05 79.38 PERITONEAL TUBERCULOSIS | 4 0.04 79.42 PERITONITIS | 3 0.03 79.45 PERSECUTORY DELUSION | 1 0.01 79.46 PETIT MAL EPILEPSY | 2 0.02 79.48 PHARYNGEAL CANCER STAGE UNSPECIFIED | 2 0.02 79.50 PHARYNGITIS | 10 0.10 79.60 PHARYNGITIS STREPTOCOCCAL | 2 0.02 79.62 PHARYNGOLARYNGEAL PAIN | 3 0.03 79.65 PHLEBITIS | 1 0.01 79.66 PHOBIA | 1 0.01 79.67 PITUITARY TUMOUR | 1 0.01 79.68 PLASMACYTOMA | 3 0.03 79.71 PLATELET AGGREGATION | 1 0.01 79.72 PNEUMOCYSTIS JIROVECI PNEUMONIA | 5 0.05 79.77 PNEUMONIA | 39 0.39 80.16 PNEUMONIA ASPIRATION | 4 0.04 80.20 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 80.21 POISONING | 1 0.01 80.22 POLLAKIURIA | 2 0.02 80.24 POLYARTERITIS NODOSA | 1 0.01 80.25 POLYARTHRITIS | 2 0.02 80.27 POLYNEUROPATHY | 4 0.04 80.31 POLYPOIDAL CHOROIDAL VASCULOPATHY | 3 0.03 80.34 POLYURIA | 1 0.01 80.35 POOR QUALITY SLEEP | 1 0.01 80.36 PORTAL HYPERTENSION | 2 0.02 80.38 PORTAL SHUNT | 1 0.01 80.39 PORTAL VEIN THROMBOSIS | 1 0.01 80.40 POST HERPETIC NEURALGIA | 1 0.01 80.41 POST-TRAUMATIC EPILEPSY | 3 0.03 80.44 POST-TRAUMATIC STRESS DISORDER | 1 0.01 80.45 POSTOPERATIVE ANALGESIA | 5 0.05 80.50 POSTOPERATIVE CARE | 2 0.02 80.52 POSTOPERATIVE INFECTION | 1 0.01 80.53 POSTPARTUM DEPRESSION | 1 0.01 80.54 POSTPARTUM HAEMORRHAGE | 1 0.01 80.55 PRE-ECLAMPSIA | 1 0.01 80.56 PRECOCIOUS PUBERTY | 1 0.01 80.57 PREGNANCY | 1 0.01 80.58 PREMATURE LABOUR | 2 0.02 80.60 PREMATURE MENOPAUSE | 3 0.03 80.63 PREMATURE RUPTURE OF MEMBRANES | 5 0.05 80.68 PREMEDICATION | 36 0.36 81.04 PREMENSTRUAL SYNDROME | 2 0.02 81.06 PRIMARY HYPOGONADISM | 1 0.01 81.07 PRIMITIVE NEUROECTODERMAL TUMOUR | 13 0.13 81.20 PROCEDURAL PAIN | 24 0.24 81.44 PRODUCTIVE COUGH | 2 0.02 81.46 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 1 0.01 81.47 PROMOTION OF PERIPHERAL CIRCULATION | 1 0.01 81.48 PROPHYLACTIC CHEMOTHERAPY | 1 0.01 81.49 PROPHYLAXIS | 130 1.30 82.79 PROPHYLAXIS AGAINST DIARRHOEA | 1 0.01 82.80 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 25 0.25 83.05 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 26 0.26 83.31 PROPHYLAXIS OF NAUSEA AND VOMITING | 13 0.13 83.44 PROSTATE CANCER | 38 0.38 83.82 PROSTATE CANCER METASTATIC | 1 0.01 83.83 PROSTATE EXAMINATION ABNORMAL | 2 0.02 83.85 PROSTATE INFECTION | 1 0.01 83.86 PROSTATIC ADENOMA | 1 0.01 83.87 PROSTATISM | 1 0.01 83.88 PROSTATITIS | 1 0.01 83.89 PROTEIN URINE PRESENT | 1 0.01 83.90 PRURITUS | 3 0.03 83.93 PSEUDOCROUP | 1 0.01 83.94 PSORIASIS | 41 0.41 84.35 PSORIATIC ARTHROPATHY | 40 0.40 84.75 PSYCHOSOMATIC DISEASE | 1 0.01 84.76 PSYCHOTIC DISORDER | 20 0.20 84.96 PULMONARY CONGESTION | 1 0.01 84.97 PULMONARY EMBOLISM | 7 0.07 85.04 PULMONARY HYPERTENSION | 26 0.26 85.30 PULMONARY MYCOSIS | 1 0.01 85.31 PULMONARY TUBERCULOSIS | 8 0.08 85.39 PURULENCE | 1 0.01 85.40 PUSTULAR PSORIASIS | 11 0.11 85.51 PYELONEPHRITIS | 3 0.03 85.54 PYELONEPHRITIS ACUTE | 3 0.03 85.57 PYOTHORAX | 2 0.02 85.59 PYREXIA | 22 0.22 85.81 Q FEVER | 1 0.01 85.82 RADIATION INJURY | 1 0.01 85.83 RADIOTHERAPY | 1 0.01 85.84 RASH | 19 0.19 86.03 RECTAL CANCER | 2 0.02 86.05 RECTAL CANCER METASTATIC | 1 0.01 86.06 RECTAL CANCER STAGE III | 3 0.03 86.09 RECTOSIGMOID CANCER | 4 0.04 86.13 REFLUX OESOPHAGITIS | 14 0.14 86.27 REFRACTORY ANAEMIA | 1 0.01 86.28 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 6 0.06 86.34 RENAL CANCER METASTATIC | 3 0.03 86.37 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 49 0.49 86.86 RENAL DISORDER | 1 0.01 86.87 RENAL FAILURE | 4 0.04 86.91 RENAL FAILURE CHRONIC | 22 0.22 87.13 RENAL TRANSPLANT | 60 0.60 87.73 RESORPTION BONE INCREASED | 8 0.08 87.81 RESPIRATORY FAILURE | 5 0.05 87.86 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 87.87 RESPIRATORY TRACT INFECTION | 2 0.02 87.89 RESPIRATORY TRACT INFECTION BACTERIAL | 1 0.01 87.90 RESTLESS LEGS SYNDROME | 11 0.11 88.01 RESTLESSNESS | 4 0.04 88.05 RESUSCITATION | 1 0.01 88.06 RETINAL ARTERY OCCLUSION | 1 0.01 88.07 RETROVIRAL INFECTION | 7 0.07 88.14 RHABDOMYOMA | 1 0.01 88.15 RHEUMATIC FEVER | 2 0.02 88.17 RHEUMATIC HEART DISEASE | 1 0.01 88.18 RHEUMATOID ARTHRITIS | 460 4.60 92.78 RHINITIS | 1 0.01 92.79 RHINITIS ALLERGIC | 7 0.07 92.86 RHINORRHOEA | 3 0.03 92.89 RIGHT VENTRICULAR FAILURE | 1 0.01 92.90 ROSACEA | 2 0.02 92.92 ROUTINE HEALTH MAINTENANCE | 3 0.03 92.95 SARCOIDOSIS | 2 0.02 92.97 SCAN MYOCARDIAL PERFUSION | 1 0.01 92.98 SCAN WITH CONTRAST | 1 0.01 92.99 SCAR PAIN | 1 0.01 93.00 SCARLET FEVER | 1 0.01 93.01 SCHIZOAFFECTIVE DISORDER | 1 0.01 93.02 SCHIZOPHRENIA | 78 0.78 93.80 SCHIZOPHRENIA, DISORGANISED TYPE | 1 0.01 93.81 SCHIZOPHRENIA, PARANOID TYPE | 11 0.11 93.92 SCHIZOPHRENIFORM DISORDER | 1 0.01 93.93 SCIATICA | 2 0.02 93.95 SCROTAL INFECTION | 1 0.01 93.96 SCROTAL PAIN | 3 0.03 93.99 SEASONAL ALLERGY | 6 0.06 94.05 SECONDARY HYPERTHYROIDISM | 1 0.01 94.06 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 94.07 SEDATION | 8 0.08 94.15 SEDATIVE THERAPY | 3 0.03 94.18 SELF ESTEEM DECREASED | 1 0.01 94.19 SELF INJURIOUS BEHAVIOUR | 1 0.01 94.20 SELF-INJURIOUS IDEATION | 1 0.01 94.21 SENSORY DISTURBANCE | 2 0.02 94.23 SEPSIS | 4 0.04 94.27 SEPTIC SHOCK | 4 0.04 94.31 SIALOADENITIS | 1 0.01 94.32 SIMPLE PARTIAL SEIZURES | 2 0.02 94.34 SINOBRONCHITIS | 2 0.02 94.36 SINUS CONGESTION | 2 0.02 94.38 SINUS DISORDER | 3 0.03 94.41 SINUSITIS | 25 0.25 94.66 SKIN PAPILLOMA | 2 0.02 94.68 SKIN ULCER | 2 0.02 94.70 SKIN WRINKLING | 5 0.05 94.75 SLEEP APNOEA SYNDROME | 1 0.01 94.76 SLEEP DISORDER | 27 0.27 95.03 SLEEP DISORDER THERAPY | 2 0.02 95.05 SMALL CELL LUNG CANCER METASTATIC | 2 0.02 95.07 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 5 0.05 95.12 SMALL INTESTINAL HAEMORRHAGE | 1 0.01 95.13 SMOKING CESSATION THERAPY | 18 0.18 95.31 SOCIAL PHOBIA | 2 0.02 95.33 SOMNOLENCE | 2 0.02 95.35 SPINAL ANAESTHESIA | 2 0.02 95.37 SPINAL COLUMN STENOSIS | 2 0.02 95.39 SPINAL COMPRESSION FRACTURE | 1 0.01 95.40 SPINAL CORD INJURY | 1 0.01 95.41 SPINAL DISORDER | 1 0.01 95.42 SPINAL MYELOGRAM | 1 0.01 95.43 SPONDYLITIS | 1 0.01 95.44 SPONDYLOARTHROPATHY | 2 0.02 95.46 SPONDYLOPATHY TRAUMATIC | 1 0.01 95.47 SQUAMOUS CELL CARCINOMA | 6 0.06 95.53 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 95.54 STAPHYLOCOCCAL INFECTION | 9 0.09 95.63 STAPHYLOCOCCAL SEPSIS | 2 0.02 95.65 STATUS EPILEPTICUS | 1 0.01 95.66 STEM CELL TRANSPLANT | 7 0.07 95.73 STENOTROPHOMONAS SEPSIS | 2 0.02 95.75 STENT PLACEMENT | 7 0.07 95.82 STOMACH DISCOMFORT | 2 0.02 95.84 STOMATITIS | 2 0.02 95.86 STREPTOCOCCAL INFECTION | 3 0.03 95.89 STRESS URINARY INCONTINENCE | 2 0.02 95.91 SUBCUTANEOUS ABSCESS | 1 0.01 95.92 SUICIDE ATTEMPT | 3 0.03 95.95 SUPERINFECTION LUNG | 2 0.02 95.97 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 96.00 SURGERY | 1 0.01 96.01 SWELLING | 1 0.01 96.02 SYPHILIS | 2 0.02 96.04 SYSTEMIC ANTIVIRAL TREATMENT | 2 0.02 96.06 SYSTEMIC CANDIDA | 3 0.03 96.09 SYSTEMIC LUPUS ERYTHEMATOSUS | 14 0.14 96.23 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 96.24 SYSTEMIC SCLEROSIS | 1 0.01 96.25 T-CELL LYMPHOMA | 4 0.04 96.29 TACHYCARDIA | 9 0.09 96.38 TAKAYASU'S ARTERITIS | 1 0.01 96.39 TEMPORAL ARTERITIS | 1 0.01 96.40 TENOSYNOVITIS STENOSANS | 1 0.01 96.41 TESTIS CANCER | 30 0.30 96.71 TETANUS | 1 0.01 96.72 THERAPEUTIC EMBOLISATION | 1 0.01 96.73 THERMAL BURN | 2 0.02 96.75 THINKING ABNORMAL | 1 0.01 96.76 THROMBOCYTOPENIA | 1 0.01 96.77 THROMBOCYTOPENIC PURPURA | 1 0.01 96.78 THROMBOSIS | 7 0.07 96.85 THROMBOSIS PROPHYLAXIS | 34 0.34 97.19 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 97.20 THYMOMA MALIGNANT | 2 0.02 97.22 THYROID DISORDER | 3 0.03 97.25 THYROIDECTOMY | 2 0.02 97.27 TINEA PEDIS | 1 0.01 97.28 TINNITUS | 1 0.01 97.29 TOCOLYSIS | 4 0.04 97.33 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 4 0.04 97.37 TONSIL CANCER | 1 0.01 97.38 TONSILLITIS | 2 0.02 97.40 TOOTH ABSCESS | 7 0.07 97.47 TOOTHACHE | 3 0.03 97.50 TORTICOLLIS | 2 0.02 97.52 TOURETTE'S DISORDER | 3 0.03 97.55 TOXIC SKIN ERUPTION | 1 0.01 97.56 TOXOPLASMOSIS | 2 0.02 97.58 TRANSGENDER HORMONAL THERAPY | 1 0.01 97.59 TRANSIENT ISCHAEMIC ATTACK | 6 0.06 97.65 TRANSITIONAL CELL CARCINOMA | 1 0.01 97.66 TRANSPLANT | 1 0.01 97.67 TRANSURETHRAL PROSTATECTOMY | 1 0.01 97.68 TRAUMATIC HAEMORRHAGE | 2 0.02 97.70 TREMOR | 4 0.04 97.74 TRIGEMINAL NERVE DISORDER | 1 0.01 97.75 TRIGEMINAL NEURALGIA | 4 0.04 97.79 TUBERCULIN TEST | 2 0.02 97.81 TUBERCULOSIS | 11 0.11 97.92 TUBERCULOSIS SKIN TEST POSITIVE | 4 0.04 97.96 TUMOUR EXCISION | 1 0.01 97.97 TUMOUR MARKER INCREASED | 1 0.01 97.98 TURNER'S SYNDROME | 2 0.02 98.00 TYPE IIA HYPERLIPIDAEMIA | 7 0.07 98.07 ULCER | 6 0.06 98.13 UNEVALUABLE EVENT | 59 0.59 98.72 UNRELATED DONOR BONE MARROW TRANSPLAN.. | 2 0.02 98.74 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 98.75 UPPER RESPIRATORY TRACT INFECTION | 3 0.03 98.78 UPPER RESPIRATORY TRACT INFLAMMATION | 2 0.02 98.80 URINARY INCONTINENCE | 2 0.02 98.82 URINARY TRACT DISORDER | 2 0.02 98.84 URINARY TRACT INFECTION | 26 0.26 99.10 UROSEPSIS | 1 0.01 99.11 URTICARIA | 3 0.03 99.14 UTERINE CANCER | 2 0.02 99.16 UTERINE HAEMORRHAGE | 1 0.01 99.17 UVEITIS | 2 0.02 99.19 VAGINAL HAEMORRHAGE | 1 0.01 99.20 VAGINAL INFECTION | 2 0.02 99.22 VAGINITIS BACTERIAL | 1 0.01 99.23 VARICOSE VEIN | 2 0.02 99.25 VASCULAR DEMENTIA | 4 0.04 99.29 VASCULAR SHUNT | 2 0.02 99.31 VASCULAR TEST | 1 0.01 99.32 VASODILATION PROCEDURE | 1 0.01 99.33 VENOUS INSUFFICIENCY | 1 0.01 99.34 VENOUS THROMBOSIS | 1 0.01 99.35 VERTEBROBASILAR INSUFFICIENCY | 2 0.02 99.37 VERTICAL INFECTION TRANSMISSION | 2 0.02 99.39 VERTIGO | 3 0.03 99.42 VIRAL HEPATITIS CARRIER | 1 0.01 99.43 VIRAL INFECTION | 3 0.03 99.46 VIRAL UPPER RESPIRATORY TRACT INFECTION | 1 0.01 99.47 VITAMIN B6 DEFICIENCY | 1 0.01 99.48 VITAMIN C | 1 0.01 99.49 VITAMIN D DEFICIENCY | 1 0.01 99.50 VITAMIN SUPPLEMENTATION | 7 0.07 99.57 VITILIGO | 4 0.04 99.61 VOMITING | 21 0.21 99.82 VULVOVAGINAL DISCOMFORT | 1 0.01 99.83 VULVOVAGINAL DRYNESS | 1 0.01 99.84 VULVOVAGINAL MYCOTIC INFECTION | 1 0.01 99.85 WALDENSTROM'S MACROGLOBULINAEMIA | 5 0.05 99.90 WEIGHT CONTROL | 2 0.02 99.92 WEIGHT DECREASED | 4 0.04 99.96 WOUND | 1 0.01 99.97 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.98 WOUND TREATMENT | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015